5PQ-18493-52149
3 vaccinations
10 coded responses
35 check-ins
10 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 787 / TX
- Registered
- 2021-04-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-22
Registered in v-safe
-
2021-04-22
Dose 1 — Moderna
-
2021-04-22
Survey response — day 0, dose 1MedDRA: Disorientation, Flushing — Feeling: Fair · HeadacheFree text: Flushed feeling and mild disorientationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, NauseaAdult check-in
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-29
- 2021-05-06
- 2021-05-13
-
2021-05-20
Dose 2 — Moderna
-
2021-05-22
Survey response — days 1–6 daily, dose 2MedDRA: Office visit — Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: PsychotherapyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-22
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-05-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessAdult check-in
- 2021-05-25
- 2021-05-26
- 2021-05-27
-
2021-06-03
Survey response — day 14, dose 2MedDRA: Chest pain, Dyspnoea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Chest pains, difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-10
Survey response — day 21, dose 2MedDRA: Depression, Dyspnoea, Gastrooesophageal reflux disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Depression, acid reflux, difficulty breathingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Survey response — day 28, dose 2MedDRA: Obsessive-compulsive disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Compulsive behaviorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-24
- 2021-07-01
-
2021-08-19
Survey response — 3 months, dose 2MedDRA: Arthralgia, Ear pain, Erythema, Headache, Myalgia, Oropharyngeal pain, Paranasal sinus hypersecretion, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Multiple fevers, extreme apex headache, muscle and joint pain, ear pain and redness, mild sore throat and sinus drainageMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-17
Dose 3 — Moderna
-
2021-11-18
Survey response — 6 months, dose 2MedDRA: Arthralgia, Frustration tolerance decreased, Patellofemoral pain syndrome, Pre-existing disease, Pyrexia — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Autistic frustration increased. Fever. Aches in joints. Level 4 chondromalacia in right knee.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-20
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-11-21
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-11-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
-
2021-11-22
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-23
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2021-12-15
- 2021-12-22
-
2021-12-29
Survey response — day 42, dose 3MedDRA: Corneal dystrophy, Depression — Feeling: Good · Be unable to do your normal daily activitiesFree text: Depression, Map Dot Fingerprint Corneal DystrophyMedDRA releases: 2024-11 · check-in free text available
-
2022-02-16
Survey response — 3 months, dose 3MedDRA: Gastritis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Gastritis and possible pancreatitisMedDRA releases: 2024-11 · check-in free text available
- 2022-05-20
-
2022-11-17
Survey response — 12 months, dose 3MedDRA: Aphasia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Temporary loss of speechMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-22 | Moderna | |
| 2 | 2021-05-20 | Moderna | |
| 3 | 2021-11-17 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Flushed feeling and mild disorientation
Release 8 — days 1–6 daily, dose 2
Healthcare visit (other): Psychotherapy
Release 8 — day 14, dose 2
Symptoms: Chest pains, difficulty breathing
Release 9 — day 21, dose 2
Symptoms: Depression, acid reflux, difficulty breathing
Release 9 — day 28, dose 2
Symptoms: Compulsive behavior
Release 9 — 3 months, dose 2
Symptoms: Multiple fevers, extreme apex headache, muscle and joint pain, ear pain and redness, mild sore throat and sinus drainage
Release 10 — 6 months, dose 2
Symptoms: Autistic frustration increased. Fever. Aches in joints. Level 4 chondromalacia in right knee.
Release 10 — day 42, dose 3
Symptoms: Depression, Map Dot Fingerprint Corneal Dystrophy
Release 11 — 3 months, dose 3
Symptoms: Gastritis and possible pancreatitis
Release 12 — 12 months, dose 3
Symptoms: Temporary loss of speech
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Aphasia | · | · | ✓ |
| SD | Arthralgia | ✓ | · | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Corneal dystrophy | · | · | ✓ |
| SD | Depression | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Ear pain | ✓ | · | ✓ |
| SD | Erythema | ✓ | · | ✓ |
| SD | Frustration tolerance decreased | · | · | ✓ |
| SD | Gastritis | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Myalgia | ✓ | · | ✓ |
| SD | Obsessive-compulsive disorder | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | Paranasal sinus hypersecretion | ✓ | · | ✓ |
| SD | Patellofemoral pain syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | ✓ | · | ✓ |
| SRO | Disorientation | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release